Tick-borne encephalitis virus can infect the nervous system and cause life-threatening illness. Finding the cellular gateway ...

Keyboard shortcuts are combinations of buttons you can press on your computer keyboard to complete certain actions, like opening and closing files, and copying and pasting text—things you would ...

The idea of creating computer programs that can mimic the brain — wasn't always accepted. But it fascinated Geoffrey Hinton.

This study provides valuable insights into human valve development by integrating snRNA-seq and spatial transcriptomics to characterize cell populations and regulatory programs in the embryonic and ...

Apple Inc. is planning to launch its own artificial intelligence-powered web search tool next year, stepping up competition with OpenAI and Perplexity AI Inc. The company is working on a new system — ...

Section 1. Crime Emergency. Two weeks ago, I declared a crime emergency in the District of Columbia to address the rampant violence and disorder that have undermined the proper and safe functioning of ...

Aug 21 (Reuters) - Gilead Sciences' (GILD.O), opens new tab unit Kite Pharma said on Thursday it will acquire privately-held biotech firm Interius BioTherapeutics for $350 million in cash to advance ...

SAVANNAH, Georgia (WJCL) — The Savannah Police Department has responded to a video circulating online that shows officers arresting a suspect on Tuesday. The above video shows two officers taking a ...

Minnesota’s Office of Cannabis Management says the law is clear that local governments cannot prohibit the establishment or operation of a licensed cannabis business. But it can't enforce the law.

Copilot is on the way to Microsoft Excel. Or rather, more Copilot is being packed into the popular spreadsheet program. A new COPILOT function is rolling out now to users in the Beta Channel and ...

Grammarly's new AI agents are designed to provide assistance without prompting. They're geared toward students and professional development. Grammarly says agents will become a major focus for the ...

Aug 15 (Reuters) - In the latest setback for Pfizer's (PFE.N), opens new tab sickle cell anemia treatments, experimental drug inclacumab failed to meet the main goal in a late-stage trial for patients ...